Private initiative makes ‘historic’ investment in autism research
Aligning Research to Impact Autism has committed more than $450 million to build a new multidisciplinary research network to uncover the roots of profound autism and develop treatments.
The Sergey Brin Family Foundation-backed initiative, Aligning Research to Impact Autism (ARIA), has made a historic $450 million investment in autism research. Since its launch in 2024, the bulk of this funding, $300 million, has been announced in the past four months. This represents a significant surge in private foundation funding for autism research, rivaling the NIH's annual budget and surpassing the Simons Foundation Autism Research Initiative's contributions of $750 to $760 million since 2006.
ARIA's grants are being allocated across six research hubs, with a focus on protein-protein interactions, human developmental neurobiology, genetic medicines, neurosensing and neuromodulation, and functional communication. The initiative's IMPACT Network, a collaboration of 20 hospitals and universities, will conduct clinical trials arising from the research hubs' efforts.
This collaborative approach, centralized biobank, and data-sharing system aim to advance the understanding of autism's causes and develop rational treatments. Notable grants include a $46 million award to the University of California, San Francisco's Quantitative Biosciences Institute (QBI) for a large-scale protein analysis project, and a $46 million grant to Harvard University and Yale University for research on brain organoids, connectomes, and single-cell genomic analyses.
These initiatives, led by experts like Nevan Krogan, Paola Arlotta, and Ekemini Riley, are poised to revolutionize the field with cutting-edge technologies and interdisciplinary research.
Written by urgent.news from The Transmitter's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
